title: Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor.
abstract: Anionic phospholipid membranes have a dual role in blood coagulation: they are essential for the initiation and propagation as well as for the limitation and termination of the blood coagulation process. Patients with the anti-phospholipid syndrome (APS) carrying antibodies against complexes of anionic phospholipids and plasma proteins, show in vitro inhibited phospholipid dependent coagulation reactions, whereas in vivo the presence of these antibodies is associated with an increased risk of thrombosis. In this study we focussed on the effects of these anti-phospholipid antibodies on the regulation of TF-mediated factor Xa (FXa) generation in plasma. We hypothesized that anti-phospholipid antibodies interfere with the phospholipid-dependent inhibition by tissue factor pathway inhibitor (TFPI) of TF-induced coagulation. Indeed, total-IgG, anti-cardiolipin-IgG (aCL) and anti-beta2GPI-IgG, isolated from patient plasmas, all stimulated TF-induced FXa generation in normal plasma. This enhanced FXa generation was not observed when the patient's IgG was depleted of anti-beta2GPI-IgG or when normal plasma was depleted of beta2PGPI or TFPI. Taken together, these data indicate that antibodies to beta2GPI, circulating in patients with APS, suppress TFPI-dependent inhibition of TF-induced coagulation, which results in an increased FXa generation.
authors.affiliation: Department of Biochemistry, Maastricht University, The Netherlands.
authors.forename: I
authors.initials: I
authors.lastname: Salemink
authors.forename: R
authors.initials: R
authors.lastname: Blezer
authors.forename: G M
authors.initials: GM
authors.lastname: Willems
authors.forename: M
authors.initials: M
authors.lastname: Galli
authors.forename: E
authors.initials: E
authors.lastname: Bevers
authors.forename: T
authors.initials: T
authors.lastname: Lindhout
mesh_terms: D016736:Antiphospholipid Syndrome / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology* / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects / Q000276:immunology; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D008074:Lipoproteins / Q000037:antagonists & inhibitors* / Q000276:immunology*; D053482:beta 2-Glycoprotein I
chemical_list: D001323:Autoantibodies; D006023:Glycoproteins; D008074:Lipoproteins; D053482:beta 2-Glycoprotein I; C051928:lipoprotein-associated coagulation inhibitor